Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Need help? Please contact us
Save to list
Save to list
CRISPR/Cas9 Cell Therapeutics – The Next Generation of Cures

CRISPR/Cas9 Cell Therapeutics – The Next Generation of Cures
Learn about strategies for using CRIPSR/Cas9 for curing genetic diseases, and the impact on next generation disease model systems and drug screening.
Hosted by GEN, Produced with Support from Lonza
The discovery of CRIPSR/Cas9 as simple and effective tool for targeted modification of cells has opened up new possibilities for gene or cell therapies. We will discuss strategies for using CRIPSR/Cas9 for curing genetic diseases, and the impact on next generation disease model systems and drug screening.
Topics Discussed:
- Introduction to CRISPR/Cas9
- Application examples with focus on use for sickle cell disease
- Opportunities and challenges for the use of CRISPR/Cas9 in gene/cell therapeutic applications
- Use of CRISPR for next generation disease model systems
- Non-viral transfer of CRISPR/Cas9 cargos and up-scaling of the transfection process
Speakers:
- Matt Porteus, MD, PhD, Associate Professor of Pediatrics, Stanford University
- Greg Alberts, PhD, Global Subject Matter Expert Transfection and Genome Editing, Lonza Bioscience Solutions
CRISPR Transfection:
- Efficient genome editing using Lonza's NucleofectorTM Technology
Important note: The user bears the sole responsibility for determining the existence of any third party rights, as well as obtaining any necessary licenses.